کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
5510211 1538855 2017 7 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
ReviewTotal laboratory automation: Do stat tests still matter?
موضوعات مرتبط
علوم زیستی و بیوفناوری بیوشیمی، ژنتیک و زیست شناسی مولکولی زیست شیمی
پیش نمایش صفحه اول مقاله
ReviewTotal laboratory automation: Do stat tests still matter?
چکیده انگلیسی


- TLA making TAT predictably short allows handling stat and ordinary tests in the same manner.
- Process management should speed up also non-analytical steps of the laboratory examination.
- Clinical governance of TLA is warranted by middleware managing all processes through a set of rules.
- Core-lab carries out first-line tests on all tubes realizing a decision making-based model.

During the past decades the healthcare systems have rapidly changed and today hospital care is primarily advocated for critical patients and acute treatments, for which laboratory test results are crucial and need to be always reported in predictably short turnaround time (TAT). Laboratories in the hospital setting can face this challenge by changing their organization from a compartmentalized laboratory department toward a decision making-based laboratory department. This requires the implementation of a core laboratory, that exploits total laboratory automation (TLA) using technological innovation in analytical platforms, track systems and information technology, including middleware, and a number of satellite specialized laboratory sections cooperating with care teams for specific medical conditions. In this laboratory department model, the short TAT for all first-line tests performed by TLA in the core laboratory represents the key paradigm, where no more stat testing is required because all samples are handled in real-time and (auto)validated results dispatched in a time that fulfills clinical needs. To optimally reach this goal, laboratories should be actively involved in managing all the steps covering the total examination process, speeding up also extra-laboratory phases, such sample delivery. Furthermore, to warrant effectiveness and not only efficiency, all the processes, e.g. specimen integrity check, should be managed by middleware through a predefined set of rules defined in light of the clinical governance.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Clinical Biochemistry - Volume 50, Issues 10–11, July 2017, Pages 605-611
نویسندگان
, , , , ,